ArticleLupus science & medicine2026
Balancing automation and expertise: real-world evaluation of AI-assisted whole-exome sequencing in lupus-causing genes.
Article in Lupus science & medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWhole-exome sequencing (WES) is increasingly used to investigate patients with suspected monogenic forms of systemic lupus erythematosus (SLE) and other systemic autoimmune rheumatic diseases (SARDs). With the increasing use of artificial intelligence (AI)-assisted variant interpretation tools, there is a need to evaluate their real-world utility. In a SARD cohort, we compared the performance of AI-assisted and expert-guided WES analysis strategies in identifying disease-relevant variants within lupus-causing genes.
methodsWe analysed WES data from 120 SARD patients using the same platform, Emedgene. For the AI-assisted analysis, a fully automated phenotype-based variant analysis produced a list of prioritised potentially disease-causing variants for each case, labelled as 'most likely'. For the expert-guided approach, expert-informed filtering criteria were applied. Both the 'most likely' AI-assisted and the expert-informed filtered variants then underwent further manual analysis.
resultsBefore manual analysis, a total of 2906 variants potentially likely to be causative were identified with the Emedgene AI tool (mean 20.8 variants per case), approximately three times fewer than the 8391 variants identified by the expert-guided method (mean 59.9 per case). A comparable number of variants (78 vs 56) in lupus-causing genes were identified at the end of the manual analysis with both methods, including two monogenic cases
conclusionsAI-assisted WES analysis substantially reduced the number of variants requiring manual review without missing the two monogenic cases. These findings support the integration of AI-assisted pipelines into genomic workflows for SLE and other SARDs which has the potential to improve efficiency and scalability of WES.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.